An overview of common non-alzheimer dementias

Clinics in Geriatric Medicine

Volumn 17, Issue 2, 2001, Pages 281-301

  Knopman, David S ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; APHASIA; CEREBROVASCULAR DISEASE; COMORBIDITY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; EXTRAPYRAMIDAL SYMPTOM; FRONTOTEMPORAL DEMENTIA; PHENOTYPE; REVIEW;

EID: 0035009084     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(05)70069-0     Document Type: Article

References (137)

1. Frequency of dementia in Parkinson disease
2. The 'subcortical dementia' of progressive supranuclear palsy
3. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study
4. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22
5. Psychiatric morbidity in dementia with Lewy bodies: A prospective clinical and neuropathological comparative study with Alzheimer's disease
6. Prevalence of parkinsonian signs and associated mortality in a community population of older people
7. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline
8. Chromosome 17 and hereditary dementia: Linkage studies in three non-Alzheimer families and kindreds with late-onset FAD
9. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration
10. REM sleep behavior disorder and degenerative dementia: An association likely reflecting Lewy body disease
11. Diagnosis of dementia: Clinicopathologic correlations
12. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study
13. Familial non-specific dementia maps to chromosome 3
14. Frontal lobe degeneration of non-Alzheimer type revisited
15. Infarctlike lesions in the brain: Prevalence and anatomic characteristics at MR imaging of the elderly-data from the Cardiovascular Health Study
16. Study methods and prevalence of dementia
17. Binswanger's disease-revisited
18. Rapidly progressive aphasic dementia and motor neuron disease
19. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
20. Cortical degeneration with swollen chromatolytic neurons: Its relationship to Pick's disease
21. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups
22. Pick's disease: Histological and clinical correlations
23. Specific pathological Tau protein variants characterize Pick's disease
24. Prevalence of Alzheimer's disease in a community population of older persons: Higher than previously reported
25. The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease
26. Neurodegenerative disorders with extensive tau pathology: A comparative study and review
27. Dementia: Case ascertainment in a community survey
28. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Conference Participants
29. Functional imaging, the frontal lobes, and dementia
30. Clinical-neuropathological correlations in Alzheimer's disease and related dementias
31. Progressive supranuclear palsy: Neuropathologic and clinical heterogeneity
32. Dementia lacking distinctive histopathology: Clinicopathological evaluation of 32 cases
33. Corticobasal degeneration
34. Neuropsychological features of progressive supranuclear palsy
35. Dementia as the most common presentation of cortical-basal ganglionic degeneration
36. Clinical picture of frontal lobe degeneration of non-Alzheimer type
37. Vascular dementia: A radical redefinition
38. Multi-infarct dementia: A cause of mental deterioration in the elderly
39. The Lewy body variant of Aizheimer's disease: A clinical and pathologic entity
40. Lewy body disease
41. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies
42. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans
43. Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: A genetic and clinicopathological study of three Dutch families
44. Comparison of Lewy body variant of Aizheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX
45. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII
46. Quantitative neuropathologic analysis of Pick's disease cases: Cortical distribution of Pick bodies and coexistence with Alzheimer's disease
47. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
48. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies
49. Dementia and motor neuron disease: Morphometric, biochemical, and Golgi studies
50. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease
51. Clinical-neuropathologic findings in multi-infarct dementia: A report of six autopsied cases
52. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
53. Why do frontal lobe symptoms predominate in vascular dementia with lacunes?
54. Clinicopathological analysis of dementia disorders in the elderly
55. Quantitative neuropathologic analysis of Pick's disease cases
56. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases
57. Positron emission tomography and histopathology in Pick's disease
58. The pathology and nosology of primary progressive aphasia
59. Pick's disease, frontotemporal dementia, and Pick complex: Emerging concepts
60. Familial dementia of adult onset with pathological findings of a 'non-specific' nature
61. Progressive aphasia without dementia: Two cases with focal spongiform degeneration
62. Dementia lacking distinctive histologic features: A common non-Alzheimer degenerative dementia
63. Dementia after ischemic stroke: A population-based study in Rochester, Minnesota
64. Ala30Pro mutation in the gene encoding alphasynuclein in Parkinson's disease
65. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study
66. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies
67. Familial progressive subcortical gliosis
68. Diagnostic evaluation of 200 elderly outpatients with suspected dementia
69. The association between midlife blood pressure levels and late-life cognitive function: The Honolulu-Asia Aging Study
70. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: The ARIC Study
71. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series
72. Cognitive and behavioral differentiation of frontal lobe degeneration of the non-Alzheimer type and Alzheimer's disease
73. Primary progressive aphasia with focal neuronal achromasia
74. Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study
75. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
76. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: A clinicopathologic study
77. Neuropsychiatric aspects of progressive supranuclear palsy
78. A quantitative MRI study of vascular dementia
79. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: The Cardiovascular Health Study
80. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study
81. Sensitivity and specificity of three clinical criteria for dementia with lewy bodies in an autopsy-verified sample
82. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex
83. The topographic distribution of brain atrophy in frontal lobe dementia
84. Dementia of frontal lobe type: Neuropathology and immunohistochemistry
85. A population-based investigation of Parkinson's disease with and without dementia: Relationship to age and gender
86. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
87. Dementia with Lewy bodies: Reliability and validity of clinical and pathologic criteria
88. Frontal lobe degeneration: Clinical, neuropsychological, and SPECT characteristics
89. A study of the Lund-Manchester research criteria for frontotemporal dementia: Clinical and single-photon emission CT correlations
90. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain
91. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias
92. Classic and generalized variants of Pick's disease: A clinicopathological, ultrastructural, and immunocytochemical comparative study
93. Frontotemporal degeneration, Pick disease, and corticobasal degeneration: One entity or 3? 3
94. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
95. Frontal lobe dementia and motor neuron disease
96. Dementia of frontal lobe type
97. Progressive subcorticai gliosis, a rare form of presenile dementia
98. Cholinergic correlates of cognitive impairment in Parkinson's dsease: Comparisons with Aizheimer's disease
99. The neuropsychoiogical pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Aizheimer's disease
100. Pathology and biology of the Lewy body
101. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
102. Tau is a candidate gene for chromosome 17 frontotemporal dementia
103. A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population
104. A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease
105. SPECT in dementia: Clinical and pathological correlation
106. Corticobasal degeneration: A clinical study of 36 cases
107. Neuropathological findings in patients with clinical diagnoses of probable Aizheimer's disease
108. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
109. Pathological verification of ischemic score in differentiation of dementias
110. Neuropsychological deficits associated with diffuse Lewy body disease
111. Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease
112. Corticobasal degeneration: Neuropathologic and clinical heterogeneity
113. The neuropathology of chromosome 17-linked dementia
114. Progressive language dysfunction and lobar atrophy
115. Brain infarction and the clinical expression of Aizheimer disease: The Nun Study
116. Linguistic ability in early life and cognitive function and Aizheimer's disease in late life: Findings from the Nun Study
117. Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathies
118. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
119. Tau protein pathology in neurodegenerative diseases
120. Familial aggregation in frontotemporal dementia
121. Neuropsychological deficits accompanying striatonigral degeneration
122. Cortical abnormalities associated with subcortical lesions in vascular dementia: Clinical and position emission tomographic findings
123. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?
124. Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort
125. Risk of dementia after stroke in a hospitalized cohort: Results of a longitudinal study
126. Mesolimbocortical dementia: A clinicopathologic case study of a putative disorder
127. Hypertension in the elderly is associated with white matter lesions and cognitive decline
128. Evaluation of the NINCDS-ADRDA criteria m he differentiation of Alzheimer's disease and frontotemporal dementia
129. Mesolimbocortical dementia: Clinico-pathological studies on two cases
130. Progressive subcortical gliosis of Neumann: A clinicopathologic study of two cases with review
131. Multicenter clinicopathological correlation in dementia
132. The clinical diagnosis of Alzheimer's disease
133. Prevalence of dementia in older Japanese American men in Hawaii: The Honolulu-Asia Aging Study
134. Epidemiology of stroke
135. Are multiple cerebral infarcts synergistic?
136. Frontal systems impairment following multiple lacunar infarcts
137. Linkage of frontotemporal dementia to chromosome 17: Clinical and neuropathological characterization of phenotype